Article | December 4, 2018

Drug Pooling – A Strategy To Significantly Reduce Overages

Source: Cenduit LLC

By Stefan Dürr, Senior Director of Project Management, and Head of the Cenduit Drug Supply Center of Excellence

supply chain

The Cenduit Drug Supply Center of Excellence (CoE) is dedicated to helping our clients use agile methods to accelerate the build of safe clinical trials, while helping to solve the industry’s 200% drug overage problem.

Another critical part of an overall supply management strategy for sponsors is understanding a growing trend in response to a need we’re seeing across global clinical trials: drug pooling.

Drug pooling is the common practice of strategically using drugs across different clinical studies to significantly reduce drug overages and maintain drug supplies for study patients. This strategy, used in conjunction with IRT, is one that the Cenduit CoE recommends, and many of our clients are exploring in response to the continued modernization and complexity of clinical trials in which a one-size-fits-all approach simply does not work.